Trials / Completed
CompletedNCT00131443
Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
A Double-Blind Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Monarch Medical Research · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
Detailed description
The objective of this study is to assess the efficacy and safety of topiramate in the prophylaxis of basilar migraine and hemiplegic migraine in children and adolescents, by comparing two doses, 25 and 100 mg/day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topiramate |
Timeline
- Start date
- 2004-02-01
- Completion
- 2006-08-01
- First posted
- 2005-08-18
- Last updated
- 2012-11-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00131443. Inclusion in this directory is not an endorsement.